Transcatheter pulmonary valve replacement is a complementary strategy to surgical replacement in managing congenital heart disease, potentially extending time between sternotomies and improving late outcomes.
Supports a sternotomy-sparing approach in congenital heart disease; leaves open the need for.
Transcatheter pulmonary valve replacement with the Melody® valve is an accepted alternative to surgical replacement of the pulmonary valve for some patients and therefore a complementary strategy in the long-term management of several groups of patients with congenital heart disease. It allows at least extending the time between sternotomies and possibly improving late outcomes. With a combined surgical and percutaneous approach, late morbidity for some of these patients will likely be diminished. This manuscript will review the current expanded applications for this technology, demonstrate several examples of its use and discuss future directions for this evolving equipment.
No takes yet. Share an insight, caveat, or question.
Ringewald et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: